EDGAR Filing Documents for 0001410578-24-000737

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:

SEC Accession No. 0001410578-24-000737

Filing Date

2024-05-10

Accepted

2024-05-10 16:10:54

Documents

115

Period of Report

2023-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	20-F	tmb-20231231x20f.htm iXBRL	20-F	3278297
2	EX-4.28	tmb-20231231xex4d28.htm	EX-4.28	95234
3	EX-4.29	tmb-20231231xex4d29.htm	EX-4.29	98246
4	EX-4.31	tmb-20231231xex4d31.htm	EX-4.31	75369
5	EX-12.1	tmb-20231231xex12d1.htm	EX-12.1	13783
6	EX-12.2	tmb-20231231xex12d2.htm	EX-12.2	13772
7	EX-13.1	tmb-20231231xex13d1.htm	EX-13.1	4910
8	EX-13.2	tmb-20231231xex13d2.htm	EX-13.2	4898
9	EX-15.1	tmb-20231231xex15d1.htm	EX-15.1	589160
10	EX-15.3	tmb-20231231xex15d3.htm	EX-15.3	5157
11	EX-97.1	tmb-20231231xex97d1.htm	EX-97.1	43277
12	GRAPHIC	tmb-20231231x20f001.jpg	GRAPHIC	34470
13	GRAPHIC	tmb-20231231x20f002.jpg	GRAPHIC	47256
14	GRAPHIC	tmb-20231231x20f003.jpg	GRAPHIC	15148
15	GRAPHIC	tmb-20231231x20f009.jpg	GRAPHIC	21654
16	GRAPHIC	tmb-20231231xex15d1001.jpg	GRAPHIC	5280
17	GRAPHIC	tmb-20231231xex97d1001.jpg	GRAPHIC	9088
	Complete submission text file	0001410578-24-000737.txt		12436794

Data Files

Seq	Description	Document	Type	Size
18	EX-101.SCH	tmb-20231231.xsd	EX-101.SCH	103474
19	EX-101.CAL	tmb-20231231_cal.xml	EX-101.CAL	52677
20	EX-101.DEF	tmb-20231231_def.xml	EX-101.DEF	280265
21	EX-101.LAB	tmb-20231231_lab.xml	EX-101.LAB	554477
22	EX-101.PRE	tmb-20231231_pre.xml	EX-101.PRE	483028
119	EXTRACTED XBRL INSTANCE DOCUMENT	tmb-20231231x20f_htm.xml	XML	2054448

Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5

Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621

XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)